Dr. Young Discusses Using Anticoagulants in Children With Cancer

Guy Young, MD
Published: Tuesday, Oct 17, 2017



Guy Young, MD, director, Hemostasis and Thrombosis Program, attending physician, Hematology, Oncology and Blood and Marrow Transplantation, Children’s Hospital Los Angeles, USC, discusses using anticoagulants in children with cancer.

Using anticoagulants in children with cancer is complicated, partly because of the increased risk of bleeding in this population, much attributed to the nature of childhood—playing sports, going to the park, or riding a bike, says Young.

Additionally, anticoagulants such as warfarin come with their own adverse events.


Guy Young, MD, director, Hemostasis and Thrombosis Program, attending physician, Hematology, Oncology and Blood and Marrow Transplantation, Children’s Hospital Los Angeles, USC, discusses using anticoagulants in children with cancer.

Using anticoagulants in children with cancer is complicated, partly because of the increased risk of bleeding in this population, much attributed to the nature of childhood—playing sports, going to the park, or riding a bike, says Young.

Additionally, anticoagulants such as warfarin come with their own adverse events.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Rare Hematology: Advancing Care and Improving Outcomes for Patients with Aplastic AnemiaAug 31, 20181.0
Community Practice Connections™: Expert Insights on the Management of Myeloproliferative Neoplasms: Evidence-based Approaches and Emerging Strategies to Address Challenges in CareSep 29, 20181.5
Publication Bottom Border
Border Publication
x